Degos' disease: A distinctive pattern of disease, chiefly of lupus erythematosus, and not a specific disease per se

American Journal of Dermatopathology

Volumn 25, Issue 4, 2003, Pages 308-320

  Ball, Elizabeth ^c   Newburger, Amy ^b   Ackerman, A Bernard ^a  

^a ACKERMAN ACADEMY OF DERMATOPATHOLOGY   (United States)

^b Dermatol Consultants of Westchester   (United States)

^c CCS 0648 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; DIPYRIDAMOLE; DNA ANTIBODY; FIBRINOGEN; IMMUNOSUPPRESSIVE AGENT; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ANTIGEN ANTIBODY COMPLEX; BLOOD CLOTTING DISORDER; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; COLLAGEN DISEASE; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; ENDOTHELIUM CELL; ERYTHEMA MULTIFORME; ERYTHEMA NODOSUM; FIBRINOLYSIS; GASTROINTESTINAL DISEASE; HISTOPATHOLOGY; HISTORY; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; LEUKOCYTOCLASTIC VASCULITIS; LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS CELL TEST; MALIGNANT ATROPHIC PAPULOSIS; MORTALITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PYODERMA GANGRENOSUM; REVIEW; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SKIN DISEASE; THROMBOCYTE AGGREGATION; THROMBOSIS; TISSUE DISTRIBUTION; TISSUE SECTION; VASCULITIS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; EPONYMS; FEMALE; HISTORY, 20TH CENTURY; HUMANS; INFANT; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, CUTANEOUS; MALE; MIDDLE AGED; PORTRAITS; SKIN DISEASES, PAPULOSQUAMOUS;

EID: 0042806056     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-200308000-00005     Document Type: Review

References (65)

1. Degos R, Delort J, Tricot R. Dermatite papulo-squameuse atrophiante. Bulletin de la Société Francaise de Dermatologie et de Syphiligraphie.; 1942:148-150.
2. Köhlmeier W. Multiple Hautnekrosen bei Thrombangiitis obliterans. Archiv für Dermatology und Syphilis. 1941;181:783-792.
3. Degos R, Delort J, Tricot R. Papulose atrophiante maligne (syndrome cutanéo-intestinal). Bulletin et Mémoires de la Société Médicale des Hopitaux de Paris. 1948;64:803.
4. Black MM. Malignant atrophic papulosis (Degos' disease). Int J Dermatol. 1976;5:405-411.
5. Tzanck A, Civatte A, Sidi E. Presentation de moulage: Ulerytheme porcelain en gouttes. Bull Soc Fr Dermatol Syphiligr. 1948;55: 10-12.
6. Naylor D, Mullins JF, Gilmore JF. Papulosis atrophicans maligna (Degos' disease): Report of the first United States case and review of the literature. Arch Dermatol. 1960;81:189-197.
7. Nomland R, Layton SM. Malignant papulosis with atrophy (Degos): Fatal cutaneo-intestinal syndrome. Arch Dermatol. 1960;81: 181-188.
8. Gever SG, Freeman RG, Knox JM Degos' disease (papulosis atrophicans maligna): Report of a case with degenerative disease of the central nervous system. South Med J. 1962;55:56-60.
9. Culicchia CF, Gol A, Erickson EE. Diffuse central nervous system involvement in papulosis atrophicans maligna. Neurology. 1962; 12:503-509.
10. Winkelman RK, Howard FM, Perry HO, et al. Malignant papulosis of skin and cerebrum: a syndrome of vascular thrombosis. Arch Dermatol. 1963;87:54-62.
11. Degos R, Kalis B. La papulose atrophiante maligne. Ann Med Interne. 1974;25:217-224.
12. Farrell AM, Moss J, Costello C, et al. Benign cutaneous Degos' disease. Br J Dermatol. 1998;139:708-712.
13. Magrinat G, Kerwin KS, Gabriel DA. The clinical manifestations of Degos' syndrome. Arch Pathol Lab Med. 1989;113:354-362.
14. Su WPD, Schroeter AL, Lee DA, et al. Clinical and histologic findings in Degos' syndrome (Malignant atrophic papulosis). Cutis. 1985;35:131-138.
15. Subbiah P, Wijdicks E, Muenter M, et al. Skin lesion with fatal neurologic outcome (Degos' disease). Neurology. 1996;46: 636-640.
16. Katz SK, Mudd LJ, Roenigk HH. Malignant atrophic papulosis (Degos' disease) involving three generations of a family. J Am Acad Dermatol. 1997;7:480-484.
17. Harvell JD, Williford PL, White WL. Benign cutaneous Degos' disease. A case report with emphasis on histopathology as papules chronologically evolve. Am J Dermatopathol. 2001;23:116-123.
18. Muller SA, Landry M. Malignant atrophic papulosis (Degos' disease). Arch Dermatol. 1976;112:357-363.
19. Howsden SM, Hodge SJ, Herndon JH, et al. Malignant atrophic papulosis of Degos. Report of a patient who failed to respond to fibrinolytic therapy. Arch Dermatol. 1976;112:1582-1588.
20. Degos R. Malignant atrophic papulosis. Br J Dermatol. 1979;100: 21-35.
21. Thomson KF, Highet AS. Penile ulceration in fatal malignant atrophic papulosis (Degos' disease). Br J Dermatol. 2000;143: 1320-1322.
22. Yoshikawa H, Maruta T, Yokoji H, Takamori M, et al. Degos' disease: radiological and immunological aspects. Acta Neurol Scand. 1996;94:353-356.
23. Dastur DK, Singhal BS, Shroff HJ. CNS involvement in malignant atrophic papulosis (Köhlmeier-Degos' disease): vasculopathy and coagulopathy. J Neurol Neuros Psych. 1981;44:156-160.
24. Strole WE, Clark WH, Isselbacher KJ. Progressive arterial occlusive disease (Köhlmeier-Degos): A frequently fatal cutaneosystemic disorder. N Engl J Med. 1967;276:195-201.
25. Feuerman EJ, Dollberg L, Salvador O. Malignant atrophic papulosis with mucin in the dermis: a clinical and pathologic study, including autopsy. Arch Path. 1970;90:310-315.
26. Pierce RN, Walker-Smith GJ. Intrathoracic manifestations of Degos' disease (Malignant atrophic papulosis). Chest. 1978;73: 79-84.
27. Mauad T, De Fatima Lopez Calvo Tiberio I, Baba E, et al. Malignant atrophic papulosis (Degos' disease) with extensive cardiopulmonary involvement. Histopathology. 1996;28:84-86.
28. Soter NA, Murphy GF, Mihm MC. Lymphocytes and necrosis of the cutaneous microvasculature in malignant atrophic papulosis: A refined light microscope study. J Am Acad Dermatol. 1982;7: 620-630.
29. Moleenar WM, Rosman JB, Donker JM, et al. The pathology and pathogenesis of malignant atrophic papulosis (Degos' disease). A case study with reference to other vascular disorders. Path Res Pract. 1987;182:98-106.
30. Tribble K, Archer ME, Jorizzo JL, et al. Malignant atrophic papulosis: Absence of circulating immune complexes or vasculitis. J Am Acad Dermatol. 1986;15:365-369.
31. Barlow RJ, Heyl T, Simson IW, et al. Malignant atrophic papulosis (Degos' disease). Diffuse involvement of brain and bowel in an African patient. Br J Dermatol. 1988;118:117-123.
32. Grilli R, Soriano L, Izquierdo J, et al. Panniculitis mimicking lupus erythematosus profundus. A new histopathologic finding in malignant atrophic papulosis (Degos' disease). Am J Dermatopathol. 1999;21:365-368.
33. Roegnik HH, Farmer RG. Degos' disease (malignant papulosis): Report of three cases with clues to etiology. J Am Acad Dermatol. 1968;206:1508-1514.
34. nd edn. Baltimore, MD: Williams & Wilkins; 1997:268-270.
35. Olmos L, Laugier P. Ultrastructural study of a new case of Degos' disease, with review of the literature). Ann Dermatol Venereol. 1977;104:280-293.
36. Plantin P, Labouche F, Sassolas B, et al. Degos' disease: A 10 year follow-up of a patient without visceral involvement. J Am Acad Dermatol. 1989;21:136-137.
37. Hall-Smith P. Malignant atrophic papulosis (Degos' disease). Two cases occurring in the same family. Br J Dermatol. 1969;81:817.
38. Moulin G, Barrut D, Franc MP, Pierson A. Papulose atrophiante de Degos familiale (mere-fille). Ann Dermatol Venereol 1984;111: 149-155.
39. Kisch LS, Bruynzeel DP. Six cases of malignant atrophic papulosis (Degos' disease) occurring in one family. Br J Dermatol. 1984; 111:469-471.
40. Habbema L, Kisch LS, Starink TM. Familial malignant atrophic papulosis (Degos' disease) additional evidence for heredity and a benign course. Br J Dermatol. 1986;114:134-135.
41. Braverman Irwin M. Skin Signs of Systemic Disease. WB Saunders Co.; 1998:409-412.
42. Stahl D, Thomsen K, Hou-Jensen K. Malignant atrophic papulosis. Treatment with aspirin and dipyridamole. Arch Dermatol. 1978; 114:1687-1689.
43. Drucker CR. Malignant atrophic papulosis: Response to antiplatelet therapy. Dermatologica. 1990;180:90-92.
44. Black MM, Nishioka K, Levene GM. The role of dermal blood vessels in the pathogenesis of malignant atrophic papulosis (Degos' disease). Br J Dermatol. 1973;88:213-219.
45. Páramo JA, Rocha E, Cuesta B, Arejola JM, et al. Fibrinolysis in Degos' disease. Thromb Haemost. 1985;54:730.
46. Vasquez-Doval FJ, Ruiz de Erenchun F, Páramo JA, et al. Malignant atrophic papulosis: A report of two cases with altered fibrinolysis and platelet function. Clin Exp Dermatol. 1993;18:441-444.
47. Englert HJ, Hawkes CH, Boey ML, et al. Degos' disease: Association with anticardiolipin antibodies and the lupus anticoagulant. Br Med J. 1984;289:576-577.
48. Howard RO, Nishida S. A case of Degos' disease with electron microscopic findings. Transact Am Ac Ophthalmol Otolaryng. 1969;73:1097-1112.
49. Rich SA, Owens TR, Anzola MC, et al. Induction of lupus inclusions by sera from patients with systemic lupus erythematosus. Arthritis Rheum. 1986;29:501-507.
50. Durie BGM, Stroud JD, Kahn JK. Progressive systemic sclerosis with malignant atrophic papulosis. Arc Dermatol. 1969;100: 575-581.
51. Dubin HV, Stawiski MA. Systemic lupus erythematosus resembling malignant atrophic papulosis. Arch Intern Med. 1974;134: 321-324.
52. Black MM, Hudson PM. Atrophie blanche lesions closely resembling malignant atrophic papulosis (Degos' disease) in systemic lupus erythematosus. Br J Dermatol. 1976;95:649-652.
53. Doutre MS, Beylot C, Bioulac P, et al. Skin lesions resembling malignant atrophic papulosis in lupus erythemathosus. Dermatologica. 1987;175:45-46.
54. Grattan CEH, Burton JL. Antiphospholipid syndrome and cutaneous vasoocclusive disorder. Semin Dermatol. 1991;10:152-159.
55. Stephansson EA, Niemi KA, Jouhikainen T, et al. Lupus anticoagulant and the skin. Acta Derm Venereol (Stockh). 1991;71: 416-422.
56. Castanet J, Lacour JPh, Perrin C, et al. Cutaneos vasculitis with lesions mimicking Degos' disease and revealing Crohn's disease. Acta Derm Venereol (Stockh). 1995;75:408-409.
57. Tsao H, Busam K, Barnhill RL, et al. Lesions resembling malignant atrophic papulosis in a patient with dermatomyositis. J Am Acad Dermatol. 1997;36:317-319.
58. Demitsu T, Kakurai M, Murata S, et al. Degos' disease associated with rheumatoid arthritis. J Dermatol. 1997;24:488-490.
59. Requena L, Farińa C, Barat A. Degos' disease in a patient with acquired immunodeficiency syndrome. J Am Acad Dermatol. 1998;38:852-856.
60. Powell J, Bordea C, Wojnarowska F, et al. Benign familial Degos' disease worsening during immunosuppression. Br J Dermatol. 1999;141:524-527.
61. Özder Güven F, Bozdag KE, Ermete M, et al. Degos' disease. Int J Dermatol 2000;39:361-362.
62. th edn. Williams and Wilkins; 1997:3-16.
63. Harris EN, Gharavi AE, Boey ML, et al. Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983;ii:1211-1212.
64. Hughes GRV. The anticardiolipin syndrome. Clin Exp Rheumatol. 1985;3:285.
65. Harris EN, Baguley E, Asherson RA, et al. Clinical and Serological features of the Antiphospholipid syndrome (APS)(abstract). Br J Rheumatol. 1987;26(Supp 2):19.